HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quantitative cytochemical differences between young and old patients with lung cancer.

Abstract
In order to study differences in the tumor growth and frequency of metastases between younger and older patients with lung cancer, we investigated the nuclear DNA and nuclear protein according to age by means of cytophotometry after combined staining with Feulgen and Naphthol Yellow S. On the basis of Feulgen-Naphthol Yellow S staining method, 13 patients less than 40 years old and 16 patients older than 70 years were investigated. Our results showed no significant difference in nuclear DNA contents between young and old patients, but there were significantly higher nuclear protein contents (p less than 0.05) and nuclear protein to nuclear DNA (NP/DNA) ratios (p less than 0.001) in young patients than in old patients. This suggests that young patients may have higher tumor proliferation (high nuclear protein contents and NP/DNA ratios). The lower nuclear protein content and NP/DNA ratio of older cases is in keeping with the general phenomenon of slower tumor growth and less frequent metastases in such cases.
AuthorsM S Huang, H Kato, C Konaka, K Nishimiya, K Yoneyama, N Kawate, H Katsunuma, Y Hayata
JournalChest (Chest) Vol. 88 Issue 6 Pg. 864-9 (Dec 1985) ISSN: 0012-3692 [Print] United States
PMID2998705 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Coloring Agents
  • Feulgen stain
  • Naphthalenesulfonates
  • Nucleoproteins
  • Rosaniline Dyes
  • naphthol yellow
  • DNA
Topics
  • Adenocarcinoma (analysis)
  • Adult
  • Age Factors
  • Aged
  • Carcinoma (analysis)
  • Carcinoma, Small Cell (analysis)
  • Carcinoma, Squamous Cell (analysis)
  • Coloring Agents
  • Cytophotometry
  • DNA (analysis)
  • Female
  • Humans
  • Lung Neoplasms (analysis)
  • Male
  • Naphthalenesulfonates
  • Nucleoproteins (analysis)
  • Rosaniline Dyes
  • Spectrophotometry

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: